This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pazoo, Inc. CEO, David Cunic, Participating In Romp To Stomp Charity Event

CEDAR KNOLLS, N.J., Jan. 18, 2013 /PRNewswire/ -- Pazoo, Inc., (OTCBB Symbol: PZOO (German WKN#: A1J3DK) is pleased to announce that CEO, David Cunic, will be participating in New Jersey's Romp to Stomp Charity Event held on January 19, 2013.

Modeled after the highly successful Race for the Cure®, the Tubbs Romp to Stomp out Breast Cancer event consists of a 3k or 5k snowshoe walk or a 3k snowshoe race.  Since starting in 2003, the Tubbs Romp to Stomp out Breast Cancer Snowshoe Series® has engaged nearly 36,000 people nationwide in the sport of snowshoeing and has raised more than 2.2 million dollars for Susan G. Komen.

The event has grown every year and is now the largest snowshoe series in the world. Romp to Stomp started in New Jersey 2008 and has had 1,183 participants to date and has raised $81,880.38 for Susan G Komen.  As a National Partner of Susan G Komen, Tubbs Snowshoes donates 100% of the donations it receives from each U.S. Romp to Stomp event, as well as all event proceeds less event costs and expenses.  The minimum guaranteed donation is $100,000

CEO of Pazoo, Inc., David Cunic, said "At Pazoo we believe in helping charities and non profit agencies as much as we can.  Many of Pazoo's Experts, staff, friends and relatives have known people who have had bouts with breast cancer.  That is why this is a special charity for us.  In addition, the leader of the organization that we are walking with has been a long time close personal friend and it is an honor and privilege to walk with her in this event."

About Pazoo, Inc.:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 -2.67%
FB $104.07 -5.81%
GOOG $683.57 -3.45%
TSLA $162.60 -7.26%
YHOO $27.97 -4.05%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs